This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 4 from Patent US 20070264275
General Information
DRACP ID DRACP01292
Peptide Name Sequence 4 from Patent US 20070264275
Sequence GLPPDVQR
Sequence Length 8
UniProt ID Q90611 P50757 P08253
PubChem CID Not available
Origin Homo sapiens
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C38H64N12O12
Absent amino acids ACEFHIKMNSTWY
Common amino acids P
Mass 100604
Pl 6.34
Basic residues 1
Acidic residues 1
Hydrophobic residues 2
Net charge 0
Boman Index -1928
Hydrophobicity -88.75
Aliphatic Index 85
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2007/0264275 A1
Patent Title Peptides Derived from the Protein Mmp-5, and the Use Thereof in Antitumoral Immunotherapy.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: US, CA, EP, JP, FR, WO; Legal Status: Inactive; Application No: 56195104; Filed:Jun 24, 2004; Published: Nov 15, 2007; Earliest Priority: Jun 25, 2003; Granted: Dec 8, 2009
Other Published ID CA2529943A1 EP1635862A1 US7629439 WO2005000342A1
This work is licensed under a Creative Commons Attribution 4.0 International License.